Non-PMI (n = 333) | PMI (n = 211) | P | |
---|---|---|---|
Angiography characteristics | |||
Number of diseased vessels | 1.7 ± 0.8 | 2.2 ± 0.9 | <0.01 |
Multi-vessel stenosis (%) | 166 (49.8%) | 157 (74.4%) | <0.01 |
Number of diseased lesions | 2.5 ± 1.6 | 3.6 ± 2.0 | <0.01 |
Average Gensini score | 30.6 ± 20.0 | 43.3 ± 26.1 | <0.01 |
Average Syntax score | 12.7 ± 6.9 | 16.9 ± 9.0 | <0.01 |
Severe CAD (%) | 237 (71.2%) | 194 (91.9%) | <0.01 |
Target lesion characteristics | --464 lesions | --357 lesions | |
A (%) | 86 (18.5%) | 53 (14.8%) | <0.01 |
B1 (%) | 106 (22.8%) | 64 (17.9%) | <0.01 |
B2 (%) | 110 (23.7%) | 90 (25.2%) | 0.048 |
C (%) | 162 (34.9%) | 150 (42.0%) | <0.01 |
PCI characteristics | |||
Number of target vessels | 1.1 ± 0.4 | 1.3 ± 0.5 | <0.01 |
Multi-vessel PCI (%) | 35 (10.5%) | 68 (32.2%) | <0.01 |
Number of implanted stents | 1.4 ± 0.6 | 1.8 ± 0.8 | <0.01 |
Total stent length (mm) | 34.7 ± 17.8 | 49.4 ± 25.9 | <0.01 |
Type of stents | |||
--Sirolimus stent (%) | 166 (49.8) | 98 (46.4) | 0.224 |
--Everolimus stent (%) | 134 (40.2) | 84 (40.0) | 0.842 |
--Others (%) | 33 (10.0) | 29 (13.6) | 0.218 |
Max inflation pressure (atm) | 13.3 ± 2.6 | 13.0 ± 1.7 | 0.762 |
Contrast volume (ml) | 144.8 ± 47.3 | 172.3 ± 63.5 | <0.01 |
Procedural complications | |||
No reflow/slow reflow | 4 (1.2%) | 2 (1.0%) | 0.682 |
Side-branch occlusion (%) | 10 (3.0%) | 12 (5.7%) | 0.064 |
Distal thrombosis | 1 (0.3%) | 1 (0.5%) | 0.342 |